Pathogenesis and Therapeutic Strategies of Jervell and Lange-Nielsen Syndrome

Yuan-feng GAO,Cui-lan LI
DOI: https://doi.org/10.3969/j.issn.1004-3934.2012.04.005
2012-01-01
Abstract:The Jervell and Lange-Nielsen syndrome(JLNS) is an autosomal recessive syndrome characterized by profound congenital bilateral sensorineural hearing loss,QT prolongation and syncope or sudden death induced by ventricular arrhythmias.JLNS has been shown to occur due to homozygous or compound heterozygous mutations in KCNQ1 or KCNE1.The mutations could debase or obliterate the functional IKs channel which was encoded by KCNQ1 and KCNE1.As a result,the duration of repolarization prolonged and so the QT interval,which would induce various ventricular arrhythmias and thusly syncopes or even sudden death;on the other hand,the decline of IKs,essential for the preservation of endolymph,would cause sensorineural deafness.JLNS is a major malignant variance of long QT syndrome with poor prognosis.β-blocker has been shown to provide limited protection against JLNS,while left cardiac sympathetic denervation and implantable cardioverter defibrillator could reduce incidences of syncope and sudden death.
What problem does this paper attempt to address?